Neurokinin B and pre-eclampsia: A decade of discovery

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Page, Nigel M ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ B; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER;

CELL INVASION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERTENSION; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVIEW; TROPHOBLAST; BLOOD; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PROGNOSIS; UPREGULATION;

BIOLOGICAL MARKERS; FEMALE; HUMANS; NEUROKININ B; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; UP-REGULATION;

EID: 76749085221     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-4     Document Type: Review

References (59)

1. Grill S, Rusterholz C, Zanetti-Dällenbach R, Tercanli S, Holzgreve W, Hahn S, Lapaire O. Potential markers of preeclampsia--a review. Reprod Biol Endocrinol 2009, 7:70-84. 10.1186/1477-7827-7-70, 2717076, 19602262.
2. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998, 16:5-15. 10.1055/s-2007-1016248, 9654603.
3. Scott JS. Pregnancy toxaemia associated with hydrops foetalis, hydatidiform mole and hydramnios. J Obstet Gynaecol Br Emp 1958, 65:689-701.
4. Page N, Butlin D, Manyonda I, Lowry P. The development of a genetic profile of placental gene expression during the first trimester of pregnancy: a potential tool for identifying novel secreted markers. Fetal Diagn Ther 2000, 15:237-245. 10.1159/000021014, 10867487.
5. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction 2002, 123:487-495. 10.1530/rep.0.1230487, 11914111.
6. Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, Manyonda IT, Lowry PJ. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 2000, 405:797-800. 10.1038/35015579, 10866201.
7. Page NM, Butlin DJ, Lomthaisong K, Lowry PJ. The characterization of pregnancy associated plasma protein-E and the identification of an alternative splice variant. Placenta 2001, 22:681-687. 10.1053/plac.2001.0709, 11597188.
8. Page NM, Butlin DJ, Lomthaisong K, Lowry PJ. The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 2001, 74:71-78. 10.1006/geno.2001.6534, 11374903.
9. Page NM, Bell NJ, Gardiner SM, Manyonda IT, Brayley KJ, Strange PG, Lowry PJ. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci USA 2003, 100:6245-6250. 10.1073/pnas.0931458100, 156357, 12716968.
10. Page NM. New challenges in the study of the mammalian tachykinins. Peptides 2005, 26:1356-1368. 10.1016/j.peptides.2005.03.030, 16042976.
11. Page NM, Lowry PJ. Is 'pre-eclampsia' simply a response to the side effects of a placental tachykinin?. J Endocrinol 2000, 167:355-361. 10.1677/joe.0.1670355, 11115762.
12. Patacchini R, Maggi CA, Holzer P. Tachykinin autoreceptors in the gut. Trends Pharmacol Sci 2000, 21:166-166. 10.1016/S0165-6147(00)01466-8, 10785646.
13. Page NM, Woods RJ, Lowry PJ. A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul Pept 2001, 98:97-104. 10.1016/S0167-0115(00)00239-1, 11231038.
14. Graham GJ, Stevens JM, Page NM, Grant AD, Brain SD, Lowry PJ, Gibbins JM. Tachykinins regulate the function of platelets. Blood 2004, 104:1058-1065. 10.1182/blood-2003-11-3979, 15130944.
15. Perianin A, Snyderman R, Malfroy B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun 1989, 161:520-524. 10.1016/0006-291X(89)92630-2, 2472137.
16. Grant AD, Akhtar R, Gerard NP, Brain SD. Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms. J Physiol 2002, 543:1007-1014. 10.1113/jphysiol.2002.018846, 2290535, 12231654.
17. Wasseff S. Mechanisms of convulsions in eclampsia. Med Hypotheses 2009, 72:49-51. 10.1016/j.mehy.2008.08.017, 18840393.
18. D'Anna R, Baviera G, Corrado F, Crisafulli A, Ientile R, Buemi M, Squadrito F. Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. BJOG 2004, 111:1046-1050. 10.1111/j.1471-0528.2004.00257.x, 15383105.
19. Geissbuehler V, Moser R, Zimmermann K, Hillermann R, Czarniecki J, Gebhardt SG, Eberhard J. Altered plasma neurokinin B levels in patients with pre-eclampsia. Arch Gynecol Obstet 2007, 276:151-157. 10.1007/s00404-006-0316-y, 17318561.
20. Zulfikaroglu E, Ugur M, Taflan S, Ugurlu N, Atalay A, Kalyoncu S. Neurokinin B levels in maternal and umbilical cord blood in preeclamptic and normal pregnancies. J Perinat Med 2007, 35:200-202. 10.1515/JPM.2007.050, 17480147.
21. Geissbuehler V, Hillermann R, Czarniecki J, Gebhardt SG, Forst S, Eberhard J, Moser R. Third trimester plasma neurokinin B levels in women with and without preeclampsia. J Matern Fetal Neonatal Med 2008, 21:95-100. 10.1080/14767050701836784, 18240076.
22. Li ZM, Zhao Y, Chen Q, Zou L, Wang ZH. Relationship between neurokinin B and endothelin-1 and hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 2008, 43:584-588.
23. Liu Y, Chen X, Chen H. Placental and umbilical cord levels of neurokinin B and neurokinin B receptor in pre-eclampsia. Int J Gynaecol Obstet 2009, 107:58-9. 10.1016/j.ijgo.2009.05.018, 19555951.
24. Page NM, Morrish DW, Weston-Bell NJ. Differential mRNA splicing and precursor processing of neurokinin B in neuroendocrine tissues. Peptides 2009, 30:1508-1513. 10.1016/j.peptides.2009.04.023, 19433124.
25. Sakamoto R, Osada H, Iitsuka Y, Masuda K, Kaku K, Seki K, Sekiya S. Profile of neurokinin B concentrations in maternal and cord blood in normal pregnancy. Clin Endocrinol (Oxf) 2003, 58:597-600. 10.1046/j.1365-2265.2003.01758.x, 12699441.
26. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008, 51:970-975. 10.1161/HYPERTENSIONAHA.107.107607, 18259009.
27. Page NM. Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides. Vascul Pharmacol 2006, 45:200-208. 10.1016/j.vph.2005.08.028, 16931167.
28. Lowry PJ. Has the mechanism by which the endocrine placenta scavenges the mother whilst sparing the foetus been unmasked?. J Mol Endocrinol 2003, 31:341-347. 10.1677/jme.0.0310341, 14664698.
29. D'Anna R, Corrado F, Baviera G, Jasonni VM. Neurokinin B peptide levels in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2002, 103:101-102. 10.1016/S0301-2115(02)00055-6, 12039478.
30. Tjoa ML, Lomecky M, Martens F, van Wijk IJ, van Vugt JM, Blankenstein MA, Oudejans CB. Neurokinin B levels in maternal circulation during early pregnancy. Clin Chem Lab Med 2004, 42:611-623. 10.1515/CCLM.2004.105, 15259376.
31. Torricelli M, Giovannelli A, Leucci E, Florio P, De Falco G, Torres PB, Reis FM, Leoncini L, Petraglia F. Placental neurokinin B mRNA expression increases at preterm labor. Placenta 2007, 28:1020-1023. 10.1016/j.placenta.2007.04.006, 17561251.
32. Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997, 18:613-621. 10.1016/S0143-4004(97)90000-X, 9364596.
33. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 1999, 354:788-789.
34. Page NM, Dakour J, Morrish DW. Gene regulation of neurokinin B and its receptor NK3 in late pregnancy and pre-eclampsia. Mol Hum Reprod 2006, 12:427-433. 10.1093/molehr/gal025, 16709596.
35. Blumenstein M, Mitchell MD, Groome NP, Keelan JA. Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta 2002, 23:735-741.
36. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001, 40:4077-4086. 10.1021/bi0023910, 11300788.
37. Sawicki G, Dakour J, Morrish DW. Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defences. Proteomics 2003, 3:2044-2051. 10.1002/pmic.200300537, 14625867.
38. Candenas ML, Magraner J, Armesto CP, Anselmi E, Nieto PM, Martín JD, Advenier C, Pinto FM. Changes in the expression of tachykinin receptors in the rat uterus during the course of pregnancy. Biol Reprod 2001, 65:538-543. 10.1095/biolreprod65.2.538, 11466223.
39. Pinto FM, Pintado CO, Pennefather JN, Patak E, Candenas L. Ovarian steroids regulate tachykinin and tachykinin receptor gene expression in the mouse uterus. Reprod Biol Endocrinol 2009, 7:77-80. 10.1186/1477-7827-7-77, 2724541, 19627578.
40. Cintado CG, Pinto FM, Devillier P, Merida A, Candenas ML. Increase in neurokinin B expression and in tachykinin NK(3) receptor-mediated response and expression in the rat uterus with age. J Pharmacol Exp Ther 2001, 299:934-938.
41. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999, 10:722-732.
42. Tofa KC, Gebhardt S, Rebello G, Geissbuehler V, Moser R, Stolk M, Hillermann R. Altered circulating neurokinin B (NKB) levels are not due to sequence variants in the encoding genes. Eur J Obstet Gynecol Reprod Biol 2008, 140:135-136. 10.1016/j.ejogrb.2007.09.003, 17976896.
43. Lowry PJ. The placenta is simply a neuroendocrine parasite. J Neuroendocrinol 2008, 20:700-704. 10.1111/j.1365-2826.2008.01737.x, 18601692.
44. Ahmed I, Glynn BP, Perkins AV, Castro MG, Rowe J, Morrison E, Linton EA. Processing of procorticotropin-releasing hormone (pro-CRH): molecular forms of CRH in normal and preeclamptic pregnancy. J Clin Endocrinol Metab 2000, 85:755-764. 10.1210/jc.85.2.755, 10690887.
45. Bicknell AB. The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol 2008, 20:692-699. 10.1111/j.1365-2826.2008.01709.x, 18601691.
46. Page NM. Hemokinins and endokinins. Cell Mol Life Sci 2004, 61:1652-1663. 10.1007/s00018-004-4035-x, 15224188.
47. Donaldson LF, Haskell CA, Hanley MR. Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor. Biochem J 1996, 320:1-5. 1217889, 8947459.
48. Page NM, Bell NJ. The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal. Eur J Pharmacol 2002, 437:27-30. 10.1016/S0014-2999(02)01278-5, 11864635.
49. Brownbill P, Bell NJ, Woods RJ, Lowry PJ, Page NM, Sibley CP. Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J Clin Endocrinol Metab 2003, 88:2164-2170. 10.1210/jc.2002-021727, 12727971.
50. Laliberte C, DiMarzo L, Morrish DW, Kaufman S. Neurokinin B causes concentration-dependent relaxation of isolated human placental resistance vessels. Regul Pept 2004, 117:123-126. 10.1016/j.regpep.2003.10.032, 14700748.
51. Yang J, Dhawan V, Morrish DW, Kaufman S. Bimodal effects of chronically administered neurokinin B (NKB) on in vivo and in vitro cardiovascular responses in female rats. Regul Pept 2007, 143:136-142. 10.1016/j.regpep.2007.05.003, 17573134.
52. Wareing M, Bhatti H, O'hara M, Kenny L, Warren AY, Taggart MJ, Baker PN. Vasoactive effects of neurokinin B on human blood vessels. Am J Obstet Gynecol 2003, 188:196-202. 10.1067/mob.2003.114, 12548217.
53. Jones S, Tucker KL, Sage T, Kaiser WJ, Barrett NE, Lowry PJ, Zimmer A, Hunt SP, Emerson M, Gibbins JM. Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood 2008, 111:605-612. 10.1182/blood-2007-07-103424, 2575837, 17895403.
54. Sibai BM, Mabie BC, Harvey CJ, Gonzalez AR. Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol 1987, 156:1174-1179.
55. Pintado CO, Pinto FM, Pennefather JN, Hidalgo A, Baamonde A, Sanchez T, Candenas ML. A role for tachykinins in female mouse and rat reproductive function. Biol Reprod 2003, 69:940-946. 10.1095/biolreprod.103.017111, 12773411.
56. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998, 59:1540-1548. 10.1095/biolreprod59.6.1540, 9828203.
57. Pal S, Wu J, Murray JK, Gellman SH, Wozniak MA, Keely PJ, Boyer ME, Gomez TM, Hasso SM, Fallon JF, Bresnick EH. An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis. J Cell Biol 2006, 174:1047-1058. 10.1083/jcb.200603152, 2064395, 17000881.
58. Lovell TM, Woods RJ, Butlin DJ, Brayley KJ, Manyonda IT, Jarvis J, Howell S, Lowry PJ. Identification of a novel mammalian post-translational modification, phosphocholine, on placental secretory polypeptides. J Mol Endocrinol 2007, 39:189-198. 10.1677/JME-07-0007, 2189575, 17766644.
59. Page NM, Weston-Bell NJ. Immunochemical methods for the peptidomic analysis of tachykinin peptides and their precursors. Methods Mol Biol 2010, 615:293-312. full_text, 20013217.